The MPA approves start of clinical trial
The Medical Products Agency approves Immunicum’s application to start a clinical phase I/II trial (EudraCT-nr 2011-002039-25) in renal cell carcinoma. The trial is expected to commence in Q1 2012.
Read the news in Nyteknik here.
Deprecated: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4973